Can Cara Therapeutics (CARA) Stock Bounce Back from Recent Selloff?

 

Cara Therapeutics Inc (CARA) stock is down -4.9% over the past week. CARA stock has risen 43.76% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives CARA stock a score of 59 out of a possible 100.

That score is primarily influenced by a long-term technical score of 71. CARA’s score also includes a short-term technical score of 61. The fundamental score for CARA is 45. In addition to the average rating from Wall Street analysts, CARA stock has a mean target price of $25.63. This means analysts expect the stock to gain 40.82% over the next 12 months.

Click Here to get the full Stock Score Report on Cara Therapeutics Inc (CARA).

What’s Happening with CARA Stock Today

Cara Therapeutics Inc (CARA) stock is down -0.16% while the S&P 500 has risen 0.3% as of 11:08 AM on Wednesday, May 15. CARA is down -$0.03 from the previous closing price of $18.23 on volume of 130,435 shares. Over the past year the S&P 500 has risen 4.13% while CARA has risen 43.76%. CARA lost -$2.10 per share in the over the last 12 months.

Symbols: CARA

You May Also Like